Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease Patients
Status:
Unknown status
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
This is a randomized, open label, phase IV, multicenter study for efficacy and safety of
lamivudine versus entecarvir therapy in HBV-related advanced liver disease patients with high
viral load and normal or slightly elevated transaminase.
Phase:
Phase 4
Details
Lead Sponsor:
Yonsei University
Collaborators:
Ajou University Bristol-Myers Squibb Chung-Ang University Hallym University Medical Center Hanyang University Inha University Hospital Inje University Kangbuk Samsung Hospital Keimyung University Konkuk University Hospital Korea University Korea University Anam Hospital Kyungpook National University Kyungpook National University Hospital Pusan National University Hospital Severance Hospital Soonchunhyang University Hospital The Catholic University of Korea